Purpose of Review

There is growing evidence supporting the use of percutaneous tibial nerve stimulation to manage lower urinary tract symptoms (LUTS) such as urgency, frequency and urge incontinence, in a non-pharmacologic, minimally invasive approach. Given this, there is now an impetus to move this technology forward from an interval (i.e., weekly and/or monthly) toward a continuous dosing, using implantable devices. This review article focuses on the newest implantable devices and the most current data demonstrating safety and efficacy in the management of refractory overactive bladder.

Recent Findings

There are new studies showing that continuous (or even semi-continuous) stimulation of the tibial nerve can be of similar efficacy as other chronic neural implant devices, such as sacral neuromodulation. This includes the Blue Wind Renova, StimGuard, eCoin, and Bioness Stimrouter.

Summary

While the data on these devices are still short-term, implantable tibial nerve stimulation holds promise in the field of managing LUTS and pelvic floor disorders. Durability and minimizing migration remain challenging.

中文翻译：

---

植入式PTNS设备的更新。

审查目的

越来越多的证据支持采用经皮胫骨神经刺激以非药物，微创方法治疗下尿路症状（LUTS），例如尿急，尿频和急迫性尿失禁。鉴于此，现在有动力使用植入式设备将该技术从一定间隔（即每周和/或每月）发展为连续给药。这篇评论文章重点介绍了最新的可植入设备和最新数据，这些数据证明了难治性膀胱过动症治疗的安全性和有效性。

最近的发现

有新的研究表明，连续（甚至半连续）刺激胫神经可能具有与其他慢性神经植入装置（例如神经调节）相似的功效。其中包括Blue Wind Renova，StimGuard，eCoin和Bioness Stimrouter。

概要

尽管这些设备的数据仍是短期的，但在控制LUTS和骨盆底疾病的领域中，植入式胫骨神经刺激术仍有希望。耐久性和最小化迁移仍然是挑战。